Role of pulmonary C fibers in adenosine-induced respiratory inhibition in anesthetized rats.
The clinical use of adenosine is commonly associated with pulmonary side effects, namely dyspnea, that suggest the possible involvement of bronchopulmonary sensory afferents. Our objective in this study was to characterize the effects of adenosine on breathing and to determine whether the vagal pulmonary afferents play a role in mediating these effects. We measured respiratory and cardiovascular changes in anesthetized, spontaneously breathing rats after bolus injections of adenosine at therapeutic doses. Right atrial injection of adenosine (0.04-0.6 mg/kg) elicits, in a dose-dependent manner, a pulmonary chemoreflex-like response consisting of a delayed apnea, bradycardia, and hypotension. In contrast, the classic capsaicin-elicited pulmonary chemoreflex occurs immediately after injection. Perineural capsaicin treatment of the cervical vagi blocked the adenosine-induced respiratory inhibition. Left ventricular administration of adenosine failed to elicit an apneic response. Pretreatment with the adenosine A1-receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine attenuated the adenosine-induced apnea. These results indicate that adenosine elicits a respiratory inhibition via stimulation of pulmonary C fibers and that activation of the A1-receptor is probably involved. It is unclear, however, what accounts for the exceedingly long latency in this response.
Kwong
K
K
Department of Physiology, University of Kentucky, Lexington 40536, USA.
Hong
J L
JL
Morton
R F
RF
Lee
L Y
LY
D000241:Adenosine / Q000008:administration & dosage / Q000633:toxicity*; D000758:Anesthesia; D000818:Animals; D002211:Capsaicin / Q000494:pharmacology; D002628:Chemoreceptor Cells / Q000187:drug effects / Q000502:physiology; D006352:Heart Ventricles; D007267:Injections; D008168:Lung / Q000187:drug effects / Q000294:innervation* / Q000502:physiology; D008297:Male; D009412:Nerve Fibers / Q000502:physiology*; D012123:Pulmonary Ventilation / Q000187:drug effects; D058915:Purinergic P1 Receptor Antagonists; D051381:Rats; D017207:Rats, Sprague-Dawley; D018047:Receptors, Purinergic P1 / Q000502:physiology; D012018:Reflex / Q000502:physiology; D012119:Respiration / Q000187:drug effects* / Q000502:physiology; D014630:Vagus Nerve / Q000502:physiology / Q000648:ultrastructure; D014970:Xanthines / Q000494:pharmacology
D058915:Purinergic P1 Receptor Antagonists; D018047:Receptors, Purinergic P1; D014970:Xanthines; C051360:1,3-dipropyl-8-cyclopentylxanthine; D000241:Adenosine; D002211:Capsaicin